Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J.

J Am Soc Nephrol. 2006 Aug;17(8):2275-84. Epub 2006 Jun 21.

2.

Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.

Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH.

J Am Soc Nephrol. 2005 Jan;16(1):180-8. Epub 2004 Nov 24.

3.
4.

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR.

J Am Soc Nephrol. 2009 May;20(5):1069-77. doi: 10.1681/ASN.2008070730. Epub 2009 Apr 8.

5.

Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study.

Tanner RM, Gutiérrez OM, Judd S, McClellan W, Bowling CB, Bradbury BD, Safford MM, Cushman M, Warnock D, Muntner P.

Am J Kidney Dis. 2013 Mar;61(3):395-403. doi: 10.1053/j.ajkd.2012.10.018. Epub 2012 Dec 8.

6.

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH.

JAMA. 2016 Aug 9;316(6):602-10. doi: 10.1001/jama.2016.10924.

7.

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.

Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR; CDC CKD Surveillance Team.

Clin J Am Soc Nephrol. 2010 Apr;5(4):673-82. doi: 10.2215/CJN.07891109. Epub 2010 Mar 25.

8.

The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).

Amin AP, Whaley-Connell AT, Li S, Chen SC, McCullough PA, Kosiborod MN; KEEP Investigators.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S12-23. doi: 10.1053/j.ajkd.2013.01.005.

10.

Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.

Heung M, Steffick DE, Zivin K, Gillespie BW, Banerjee T, Hsu CY, Powe NR, Pavkov ME, Williams DE, Saran R, Shahinian VB; Centers for Disease Control and Prevention CKD Surveillance Team.

Am J Kidney Dis. 2016 May;67(5):742-52. doi: 10.1053/j.ajkd.2015.10.019. Epub 2015 Dec 12.

PMID:
26690912
11.

Prevalence of chronic kidney disease in the United States.

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS.

JAMA. 2007 Nov 7;298(17):2038-47.

PMID:
17986697
12.

Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.

Hallan SI, Øvrehus MA, Romundstad S, Rifkin D, Langhammer A, Stevens PE, Ix JH.

Kidney Int. 2016 Sep;90(3):665-73. doi: 10.1016/j.kint.2016.04.012. Epub 2016 Jun 22.

PMID:
27344204
13.

Chronic kidney disease in the United States: an underrecognized problem.

Obrador GT, Pereira BJ, Kausz AT.

Semin Nephrol. 2002 Nov;22(6):441-8. Review.

PMID:
12430088
14.

Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study.

Minutolo R, Lapi F, Chiodini P, Simonetti M, Bianchini E, Pecchioli S, Cricelli I, Cricelli C, Piccinocchi G, Conte G, De Nicola L.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1586-93. doi: 10.2215/CJN.10481013. Epub 2014 Jul 29.

15.

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS.

JAMA. 2014 Jun 25;311(24):2518-2531. doi: 10.1001/jama.2014.6634.

16.

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.

Hsu CY, Lin F, Vittinghoff E, Shlipak MG.

J Am Soc Nephrol. 2003 Nov;14(11):2902-7.

17.

Trends in diabetes, high cholesterol, and hypertension in chronic kidney disease among U.S. adults: 1988-1994 to 1999-2004.

Fox CS, Muntner P.

Diabetes Care. 2008 Jul;31(7):1337-42. doi: 10.2337/dc07-2348. Epub 2008 Apr 24.

18.

Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.

Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R.

J Hypertens. 2010 Jan;28(1):156-62. doi: 10.1097/HJH.0b013e328332038c.

PMID:
19915481
19.

Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations.

Peralta CA, Lin F, Shlipak MG, Siscovick D, Lewis C, Jacobs DR Jr, Bibbins-Domingo K.

Nephrol Dial Transplant. 2010 Dec;25(12):3934-9. doi: 10.1093/ndt/gfq299. Epub 2010 Jun 2.

20.

Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP).

Chang TI, Li S, Chen SC, Peralta CA, Shlipak MG, Fried LF, Whaley-Connell AT, McCullough PA, Tamura MK; KEEP Investigators.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S4-11. doi: 10.1053/j.ajkd.2012.12.016.

Supplemental Content

Support Center